Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1

Interventions

aldesleukin 65 Cyclophosphamide 45 fludarabine phosphate 30 fludarabine 27 Interleukin-2 24 incomplete Freund's adjuvant 22 Ipilimumab 17 Specimen Handling 14 MART-1 Antigen 14 CTLA-4 Antigen 14 sargramostim 13 Magnetic Resonance Spectroscopy 13 Biopsy 13 montanide ISA 51 11 Nivolumab 11 Filgrastim 11 Sorafenib 10 Interferon-alpha 9 trametinib 8 pembrolizumab 8 dabrafenib 8 Sirolimus 7 Bevacizumab 7 temsirolimus 6 Temozolomide 6 Taxes 5 Paclitaxel 5 Introns 5 Gene Expression Profiling 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Melanoma × saponin QA-21V1 × Clear all

NCT00005052 2009-02-09

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

National Cancer Institute (NCI)

Phase 3 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡